Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality?
- PMID: 40004829
- PMCID: PMC11856706
- DOI: 10.3390/jcm14041299
Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality?
Abstract
Women with adverse pregnancy outcomes suggestive of obstetric antiphospholipid syndrome (OAPS), but not fulfilling clinical and/or laboratory international classification criteria, are increasingly recognized both in clinical practice and in the literature. This entity is termed non-criteria OAPS (NC-OAPS). It includes clinical scenarios such as two unexplained pregnancy losses, three non-consecutive pregnancy losses, late pre-eclampsia/eclampsia/signs of placental insufficiency, or recurrent implantation failure, as well as positive low-titers of antiphospholipid antibodies (aPLs) and non-classical aPLs. To address the NC-OAPS heterogeneity, a nomenclature proposal was developed. In recent years, retrospective and prospective cohort studies have been designed to clarify the characteristics and outcomes of the different subsets of NC-OAPS. In general, the studies support that NC-OAPS may benefit from treatment with antithrombotic, anticoagulant and/or immunomodulator agents, but several considerations must be made on the robustness and nuances of the scientific evidence. The objective of this review is to critically analyze the available evidence supporting the diagnosis of NC-OAPS, categorize its subsets, and evaluate the impact of treatment strategies on its outcome. We also remark on questions that are still unanswered, such as the lack of consensus on diagnostic criteria or treatment protocols.
Keywords: infertility; low-titer aPL; non-criteria obstetric antiphospholipid syndrome; recurrent implantation failure.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
[Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):513-520. doi: 10.12182/20240560104. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38948301 Free PMC article. Review. Chinese.
-
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.Rheumatology (Oxford). 2020 Jun 1;59(6):1306-1314. doi: 10.1093/rheumatology/kez419. Rheumatology (Oxford). 2020. PMID: 31580459
-
Pregnancy Outcomes in Non-Criteria Obstetric Antiphospholipid Syndrome: Analysis of a Cohort of 91 Patients.J Clin Med. 2024 Dec 23;13(24):7862. doi: 10.3390/jcm13247862. J Clin Med. 2024. PMID: 39768785 Free PMC article.
-
Clinical Features Between Primary Obstetric Antiphospholipid Syndrome and Non-Criteria Obstetric Antiphospholipid Syndrome and Risk Factors of Adverse Pregnancy Outcomes: A Retrospective Study of 1006 Cases.Am J Reprod Immunol. 2024 Sep;92(3):e13931. doi: 10.1111/aji.13931. Am J Reprod Immunol. 2024. PMID: 39319996
-
Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review.J Clin Med. 2022 Jan 28;11(3):675. doi: 10.3390/jcm11030675. J Clin Med. 2022. PMID: 35160128 Free PMC article. Review.
Cited by
-
B Cell Tolerance and Obstetric Antiphospholipid Syndrome.Clin Rev Allergy Immunol. 2025 Jun 8;68(1):55. doi: 10.1007/s12016-025-09064-z. Clin Rev Allergy Immunol. 2025. PMID: 40483664 Review.
References
-
- Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H.W.M., De Groot P.G., Koike T., Meroni P.L., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J. Thromb. Haemost. 2006;4:295–306. doi: 10.1111/j.1538-7836.2006.01753.x. - DOI - PubMed
-
- Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.-C., Brey R., Derksen R., Harris E.N., Hughes G.R.V., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheumatol. 1999;42:1309–1311. doi: 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F. - DOI - PubMed
-
- Martínez-Taboada V.M., Gómez A.M., del Barrio-Longarela S., Merino A., Comins-Boo A., López-Hoyos M., Riancho-Zarrabeitia L., Gálvez R., Hernández J.L. Impact of the 2023 ACR/EULAR Classification Criteria in Women with Primary Antiphospholipid Syndrome during Pregnancy. Diagnostics. 2024;14:2162. doi: 10.3390/diagnostics14192162. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources